⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TARA News
Protara Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
TARA
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
globenewswire.com
TARA
Form 8-K
sec.gov
TARA
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
globenewswire.com
TARA
Protara Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
TARA
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TARA
Protara Therapeutics to Present Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Unresponsive NMIBC Patients at the ASCO Genitourinary Cancers Symposium
globenewswire.com
TARA
TARA Media, SWYM.ai Bring AI-Powered Supply Shaping to Media Buying Platform
prnewswire.com
TARA
Telecom Site Management Software Market to Surpass USD 792.48 Million by 2033, Driven by 5G Expansion and Growing Tower Deployments | Research by SNS Insider
globenewswire.com
TARA
Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones
globenewswire.com
TARA